Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets Article Swipe

PDF

Valérie Leclair , Thaisa Cotton , Hao Cheng Shen , Claudie Berger , Yves Troyanov , Marie Hudson , Geneviève Gyger ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1093/rheumatology/keaf594

Objectives Nailfold videocapillaroscopy (NVC) alterations have been described in autoimmune inflammatory myopathies (AIM). This study aimed to describe NVC abnormalities in AIM subsets using a clinico-sero-pathological approach. Methods We studied subjects from the Canadian Inflammatory Myopathy Study (CIMS), a prospective AIM cohort. NVC images were acquired using the DS MEDICA Videocap (X200 magnification). Capillary density was scored quantitatively and semi-quantitatively. Ectasias, giant capillaries, ramified capillaries and microhemorrhages were scored as present or absent and with a standardized semi-quantitative scale (0 = none, 1 = ≤33%, 2 = 33–66%, and 3 = ≥66% abnormal capillaries/total capillaries per mm). NVC patterns (i.e. scleroderma early/active/late, scleroderma-like, non-specific, and normal) were described. NVC features and patterns were compared between AIM subsets. Results We included 99 AIM subjects: 41 dermatomyositis, 24 scleromyositis, 16 anti-synthetase syndrome, 7 immune-mediated necrotizing myopathy, 8 inclusion body myositis and 3 polymyositis. 71% were female, and the median disease duration was 1 year [IQR; 0.4–2.8]. The most frequent NVC abnormality was decreased capillary density in dermatomyositis (95%), scleromyositis (92%) and anti-synthetase syndrome (87%). Qualitatively, 44% of subjects had abnormal NVC, 25% non-specific NVC abnormalities, and 30% normal NVC. NVC patterns were not discriminant between dermatomyositis, scleromyositis and anti-synthetase syndrome. NVC abnormalities were absent in immune-mediated necrotizing myopathy, inclusion body myositis and polymyositis. Conclusion Dermatomyositis, scleromyositis and anti-synthetase syndrome showed frequent NVC abnormalities, although no NVC pattern was associated with a particular subset in our study. However, NVC may help distinguish between these subsets and immune-mediated necrotizing myopathy, inclusion body myositis and polymyositis.

Related Topics

Concepts

Dermatomyositis Medicine Inclusion body myositis Inflammatory myopathy Pathology Myopathy Myositis Overlap syndrome Autoimmune disease Polymyositis Dermatology Abnormality Internal medicine Autoantibody

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1093/rheumatology/keaf594
PDF: https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf594/65224393/keaf594.pdf
OA Status: hybrid
OpenAlex ID: https://openalex.org/W7104468690

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W7104468690

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1093/rheumatology/keaf594

Digital Object Identifier
Title: Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-11-05

Full publication date if available
Authors: Valérie Leclair, Thaisa Cotton, Hao Cheng Shen, Claudie Berger, Yves Troyanov, Marie Hudson, Geneviève Gyger

List of authors in order
Landing page: https://doi.org/10.1093/rheumatology/keaf594

Publisher landing page
PDF URL: https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf594/65224393/keaf594.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: hybrid

Open access status per OpenAlex
OA URL: https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf594/65224393/keaf594.pdf

Direct OA link when available
Concepts: Dermatomyositis, Medicine, Inclusion body myositis, Inflammatory myopathy, Pathology, Myopathy, Myositis, Overlap syndrome, Autoimmune disease, Polymyositis, Dermatology, Abnormality, Internal medicine, Autoantibody

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex

Full payload

id	https://openalex.org/W7104468690
doi	https://doi.org/10.1093/rheumatology/keaf594
ids.doi	https://doi.org/10.1093/rheumatology/keaf594
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/41206056
ids.openalex	https://openalex.org/W7104468690
fwci	0.0
type	article
title	Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11724
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9869986176490784
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2713
topics[0].subfield.display_name	Epidemiology
topics[0].display_name	Inflammatory Myopathies and Dermatomyositis
topics[1].id	https://openalex.org/T11330
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.006875886581838131
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2734
topics[1].subfield.display_name	Pathology and Forensic Medicine
topics[1].display_name	Systemic Sclerosis and Related Diseases
topics[2].id	https://openalex.org/T12433
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.001766412635333836
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2708
topics[2].subfield.display_name	Dermatology
topics[2].display_name	Skin Diseases and Diabetes
is_xpac	False
apc_list.value	3192
apc_list.currency	GBP
apc_list.value_usd	3915
apc_paid.value	3192
apc_paid.currency	GBP
apc_paid.value_usd	3915
concepts[0].id	https://openalex.org/C2778751314
concepts[0].level	2
concepts[0].score	0.7979452610015869
concepts[0].wikidata	https://www.wikidata.org/wiki/Q681160
concepts[0].display_name	Dermatomyositis
concepts[1].id	https://openalex.org/C71924100
concepts[1].level	0
concepts[1].score	0.7900714874267578
concepts[1].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[1].display_name	Medicine
concepts[2].id	https://openalex.org/C2777327098
concepts[2].level	3
concepts[2].score	0.7505826950073242
concepts[2].wikidata	https://www.wikidata.org/wiki/Q1848471
concepts[2].display_name	Inclusion body myositis
concepts[3].id	https://openalex.org/C2780181341
concepts[3].level	3
concepts[3].score	0.7435277104377747
concepts[3].wikidata	https://www.wikidata.org/wiki/Q4117658
concepts[3].display_name	Inflammatory myopathy
concepts[4].id	https://openalex.org/C142724271
concepts[4].level	1
concepts[4].score	0.6091782450675964
concepts[4].wikidata	https://www.wikidata.org/wiki/Q7208
concepts[4].display_name	Pathology
concepts[5].id	https://openalex.org/C2777300911
concepts[5].level	2
concepts[5].score	0.5987116098403931
concepts[5].wikidata	https://www.wikidata.org/wiki/Q692536
concepts[5].display_name	Myopathy
concepts[6].id	https://openalex.org/C2781232998
concepts[6].level	2
concepts[6].score	0.4204184412956238
concepts[6].wikidata	https://www.wikidata.org/wiki/Q1433212
concepts[6].display_name	Myositis
concepts[7].id	https://openalex.org/C2775941666
concepts[7].level	3
concepts[7].score	0.4067598283290863
concepts[7].wikidata	https://www.wikidata.org/wiki/Q7113759
concepts[7].display_name	Overlap syndrome
concepts[8].id	https://openalex.org/C2779075594
concepts[8].level	3
concepts[8].score	0.35913601517677307
concepts[8].wikidata	https://www.wikidata.org/wiki/Q8084905
concepts[8].display_name	Autoimmune disease
concepts[9].id	https://openalex.org/C2779387793
concepts[9].level	2
concepts[9].score	0.35846060514450073
concepts[9].wikidata	https://www.wikidata.org/wiki/Q980926
concepts[9].display_name	Polymyositis
concepts[10].id	https://openalex.org/C16005928
concepts[10].level	1
concepts[10].score	0.32116636633872986
concepts[10].wikidata	https://www.wikidata.org/wiki/Q171171
concepts[10].display_name	Dermatology
concepts[11].id	https://openalex.org/C50965678
concepts[11].level	2
concepts[11].score	0.303955078125
concepts[11].wikidata	https://www.wikidata.org/wiki/Q2724302
concepts[11].display_name	Abnormality
concepts[12].id	https://openalex.org/C126322002
concepts[12].level	1
concepts[12].score	0.2580184042453766
concepts[12].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[12].display_name	Internal medicine
concepts[13].id	https://openalex.org/C163764329
concepts[13].level	3
concepts[13].score	0.25230157375335693
concepts[13].wikidata	https://www.wikidata.org/wiki/Q785022
concepts[13].display_name	Autoantibody
keywords[0].id	https://openalex.org/keywords/dermatomyositis
keywords[0].score	0.7979452610015869
keywords[0].display_name	Dermatomyositis
keywords[1].id	https://openalex.org/keywords/inclusion-body-myositis
keywords[1].score	0.7505826950073242
keywords[1].display_name	Inclusion body myositis
keywords[2].id	https://openalex.org/keywords/inflammatory-myopathy
keywords[2].score	0.7435277104377747
keywords[2].display_name	Inflammatory myopathy
keywords[3].id	https://openalex.org/keywords/myopathy
keywords[3].score	0.5987116098403931
keywords[3].display_name	Myopathy
keywords[4].id	https://openalex.org/keywords/myositis
keywords[4].score	0.4204184412956238
keywords[4].display_name	Myositis
keywords[5].id	https://openalex.org/keywords/overlap-syndrome
keywords[5].score	0.4067598283290863
keywords[5].display_name	Overlap syndrome
language	en
locations[0].id	doi:10.1093/rheumatology/keaf594
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S183989336
locations[0].source.issn	1462-0324, 1462-0332
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	1462-0324
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Lara D. Veeken
locations[0].source.host_organization	https://openalex.org/P4310311648
locations[0].source.host_organization_name	Oxford University Press
locations[0].source.host_organization_lineage	https://openalex.org/P4310311648
locations[0].license	cc-by-nc
locations[0].pdf_url	https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf594/65224393/keaf594.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Rheumatology
locations[0].landing_page_url	https://doi.org/10.1093/rheumatology/keaf594
locations[1].id	pmid:41206056
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	Rheumatology (Oxford, England)
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/41206056
indexed_in	crossref, pubmed
authorships[0].author.id	https://openalex.org/A2541519852
authorships[0].author.orcid	https://orcid.org/0000-0001-8643-6697
authorships[0].author.display_name	Valérie Leclair
authorships[0].countries	CA
authorships[0].affiliations[0].institution_ids	https://openalex.org/I5023651
authorships[0].affiliations[0].raw_affiliation_string	Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.
authorships[0].affiliations[1].institution_ids	https://openalex.org/I2801824472
authorships[0].affiliations[1].raw_affiliation_string	Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
authorships[0].institutions[0].id	https://openalex.org/I2801824472
authorships[0].institutions[0].ror	https://ror.org/https://ror.org/056jjra10
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I2801824472
authorships[0].institutions[0].country_code	CA
authorships[0].institutions[0].display_name	Jewish General Hospital
authorships[0].institutions[1].id	https://openalex.org/I5023651
authorships[0].institutions[1].ror	https://ror.org/https://ror.org/01pxwe438
authorships[0].institutions[1].type	education
authorships[0].institutions[1].lineage	https://openalex.org/I5023651
authorships[0].institutions[1].country_code	CA
authorships[0].institutions[1].display_name	McGill University
authorships[0].author_position	first
authorships[0].raw_author_name	Valérie Leclair
authorships[0].is_corresponding	True
authorships[0].raw_affiliation_strings	Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada., Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
authorships[1].author.id	https://openalex.org/A3121811647
authorships[1].author.orcid
authorships[1].author.display_name	Thaisa Cotton
authorships[1].countries	CA
authorships[1].affiliations[0].institution_ids	https://openalex.org/I5023651
authorships[1].affiliations[0].raw_affiliation_string	Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.
authorships[1].institutions[0].id	https://openalex.org/I5023651
authorships[1].institutions[0].ror	https://ror.org/https://ror.org/01pxwe438
authorships[1].institutions[0].type	education
authorships[1].institutions[0].lineage	https://openalex.org/I5023651
authorships[1].institutions[0].country_code	CA
authorships[1].institutions[0].display_name	McGill University
authorships[1].author_position	middle
authorships[1].raw_author_name	Thaisa Cotton
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.
authorships[2].author.id	https://openalex.org/A2901623148
authorships[2].author.orcid	https://orcid.org/0009-0002-2452-3511
authorships[2].author.display_name	Hao Cheng Shen
authorships[2].countries	CA
authorships[2].affiliations[0].institution_ids	https://openalex.org/I5023651
authorships[2].affiliations[0].raw_affiliation_string	Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.
authorships[2].institutions[0].id	https://openalex.org/I5023651
authorships[2].institutions[0].ror	https://ror.org/https://ror.org/01pxwe438
authorships[2].institutions[0].type	education
authorships[2].institutions[0].lineage	https://openalex.org/I5023651
authorships[2].institutions[0].country_code	CA
authorships[2].institutions[0].display_name	McGill University
authorships[2].author_position	middle
authorships[2].raw_author_name	Hao Cheng Shen
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.
authorships[3].author.id	https://openalex.org/A2167161858
authorships[3].author.orcid	https://orcid.org/0000-0002-5499-2661
authorships[3].author.display_name	Claudie Berger
authorships[3].countries	CA
authorships[3].affiliations[0].institution_ids	https://openalex.org/I2801766832
authorships[3].affiliations[0].raw_affiliation_string	Research Institute of the McGill University Health Centre, Montreal, Canada.
authorships[3].institutions[0].id	https://openalex.org/I2801766832
authorships[3].institutions[0].ror	https://ror.org/https://ror.org/04cpxjv19
authorships[3].institutions[0].type	funder
authorships[3].institutions[0].lineage	https://openalex.org/I2801766832
authorships[3].institutions[0].country_code	CA
authorships[3].institutions[0].display_name	McGill University Health Centre
authorships[3].author_position	middle
authorships[3].raw_author_name	Claudie Berger
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Research Institute of the McGill University Health Centre, Montreal, Canada.
authorships[4].author.id	https://openalex.org/A1872276710
authorships[4].author.orcid
authorships[4].author.display_name	Yves Troyanov
authorships[4].affiliations[0].raw_affiliation_string	Division of Rheumatology, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montreal, Quebec, Canada.
authorships[4].author_position	middle
authorships[4].raw_author_name	Yves Troyanov
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Division of Rheumatology, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montreal, Quebec, Canada.
authorships[5].author.id	https://openalex.org/A2147651501
authorships[5].author.orcid	https://orcid.org/0000-0001-6718-2468
authorships[5].author.display_name	Marie Hudson
authorships[5].countries	CA
authorships[5].affiliations[0].institution_ids	https://openalex.org/I5023651
authorships[5].affiliations[0].raw_affiliation_string	Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.
authorships[5].affiliations[1].institution_ids	https://openalex.org/I2801824472
authorships[5].affiliations[1].raw_affiliation_string	Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
authorships[5].institutions[0].id	https://openalex.org/I2801824472
authorships[5].institutions[0].ror	https://ror.org/https://ror.org/056jjra10
authorships[5].institutions[0].type	healthcare
authorships[5].institutions[0].lineage	https://openalex.org/I2801824472
authorships[5].institutions[0].country_code	CA
authorships[5].institutions[0].display_name	Jewish General Hospital
authorships[5].institutions[1].id	https://openalex.org/I5023651
authorships[5].institutions[1].ror	https://ror.org/https://ror.org/01pxwe438
authorships[5].institutions[1].type	education
authorships[5].institutions[1].lineage	https://openalex.org/I5023651
authorships[5].institutions[1].country_code	CA
authorships[5].institutions[1].display_name	McGill University
authorships[5].author_position	middle
authorships[5].raw_author_name	Marie Hudson
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada., Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
authorships[6].author.id	https://openalex.org/A1995660848
authorships[6].author.orcid
authorships[6].author.display_name	Geneviève Gyger
authorships[6].countries	CA
authorships[6].affiliations[0].institution_ids	https://openalex.org/I5023651
authorships[6].affiliations[0].raw_affiliation_string	Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.
authorships[6].institutions[0].id	https://openalex.org/I5023651
authorships[6].institutions[0].ror	https://ror.org/https://ror.org/01pxwe438
authorships[6].institutions[0].type	education
authorships[6].institutions[0].lineage	https://openalex.org/I5023651
authorships[6].institutions[0].country_code	CA
authorships[6].institutions[0].display_name	McGill University
authorships[6].author_position	middle
authorships[6].raw_author_name	Geneviève Gyger
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.
authorships[7].author.id	https://openalex.org/A4201025057
authorships[7].author.orcid	https://orcid.org/0000-0003-1532-3366
authorships[7].author.display_name
authorships[7].author_position	last
authorships[7].raw_author_name
authorships[7].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf594/65224393/keaf594.pdf
open_access.oa_status	hybrid
open_access.any_repository_has_fulltext	False
created_date	2025-11-09T00:00:00
display_name	Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets
has_fulltext	False
is_retracted	False
updated_date	2025-11-09T23:12:50.468023
primary_topic.id	https://openalex.org/T11724
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9869986176490784
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2713
primary_topic.subfield.display_name	Epidemiology
primary_topic.display_name	Inflammatory Myopathies and Dermatomyositis
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1093/rheumatology/keaf594
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S183989336
best_oa_location.source.issn	1462-0324, 1462-0332
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	1462-0324
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Lara D. Veeken
best_oa_location.source.host_organization	https://openalex.org/P4310311648
best_oa_location.source.host_organization_name	Oxford University Press
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310311648
best_oa_location.license	cc-by-nc
best_oa_location.pdf_url	https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf594/65224393/keaf594.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Rheumatology
best_oa_location.landing_page_url	https://doi.org/10.1093/rheumatology/keaf594
primary_location.id	doi:10.1093/rheumatology/keaf594
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S183989336
primary_location.source.issn	1462-0324, 1462-0332
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	1462-0324
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Lara D. Veeken
primary_location.source.host_organization	https://openalex.org/P4310311648
primary_location.source.host_organization_name	Oxford University Press
primary_location.source.host_organization_lineage	https://openalex.org/P4310311648
primary_location.license	cc-by-nc
primary_location.pdf_url	https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf594/65224393/keaf594.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Rheumatology
primary_location.landing_page_url	https://doi.org/10.1093/rheumatology/keaf594
publication_date	2025-11-05
publication_year	2025
referenced_works_count	0
abstract_inverted_index.1	83, 151
abstract_inverted_index.2	86
abstract_inverted_index.3	90, 140
abstract_inverted_index.7	131
abstract_inverted_index.8	135
abstract_inverted_index.=	81, 84, 87, 91
abstract_inverted_index.a	25, 39, 76, 229
abstract_inverted_index.(0	80
abstract_inverted_index.16	128
abstract_inverted_index.24	126
abstract_inverted_index.41	124
abstract_inverted_index.99	121
abstract_inverted_index.DS	49
abstract_inverted_index.We	29, 119
abstract_inverted_index.as	70
abstract_inverted_index.in	9, 21, 164, 203, 232
abstract_inverted_index.no	223
abstract_inverted_index.of	175
abstract_inverted_index.or	72
abstract_inverted_index.to	17
abstract_inverted_index.25%	180
abstract_inverted_index.30%	185
abstract_inverted_index.44%	174
abstract_inverted_index.71%	142
abstract_inverted_index.AIM	22, 41, 116, 122
abstract_inverted_index.NVC	19, 43, 98, 109, 158, 182, 188, 199, 220, 224, 236
abstract_inverted_index.The	155
abstract_inverted_index.and	59, 66, 74, 89, 105, 111, 139, 145, 169, 184, 196, 210, 215, 243, 250
abstract_inverted_index.had	177
abstract_inverted_index.may	237
abstract_inverted_index.not	191
abstract_inverted_index.our	233
abstract_inverted_index.per	96
abstract_inverted_index.the	33, 48, 146
abstract_inverted_index.was	56, 150, 160, 226
abstract_inverted_index.NVC,	179
abstract_inverted_index.NVC.	187
abstract_inverted_index.This	14
abstract_inverted_index.been	7
abstract_inverted_index.body	137, 208, 248
abstract_inverted_index.from	32
abstract_inverted_index.have	6
abstract_inverted_index.help	238
abstract_inverted_index.mm).	97
abstract_inverted_index.most	156
abstract_inverted_index.were	45, 68, 107, 113, 143, 190, 201
abstract_inverted_index.with	75, 228
abstract_inverted_index.year	152
abstract_inverted_index.(92%)	168
abstract_inverted_index.(NVC)	4
abstract_inverted_index.(X200	52
abstract_inverted_index.(i.e.	100
abstract_inverted_index.Study	37
abstract_inverted_index.[IQR;	153
abstract_inverted_index.aimed	16
abstract_inverted_index.giant	62
abstract_inverted_index.none,	82
abstract_inverted_index.scale	79
abstract_inverted_index.study	15
abstract_inverted_index.these	241
abstract_inverted_index.using	24, 47
abstract_inverted_index.(87%).	172
abstract_inverted_index.(95%),	166
abstract_inverted_index.(AIM).	13
abstract_inverted_index.MEDICA	50
abstract_inverted_index.absent	73, 202
abstract_inverted_index.images	44
abstract_inverted_index.median	147
abstract_inverted_index.normal	186
abstract_inverted_index.scored	57, 69
abstract_inverted_index.showed	218
abstract_inverted_index.study.	234
abstract_inverted_index.subset	231
abstract_inverted_index.≥66%	92
abstract_inverted_index.(CIMS),	38
abstract_inverted_index.Methods	28
abstract_inverted_index.Results	118
abstract_inverted_index.between	115, 193, 240
abstract_inverted_index.cohort.	42
abstract_inverted_index.density	55, 163
abstract_inverted_index.disease	148
abstract_inverted_index.female,	144
abstract_inverted_index.normal)	106
abstract_inverted_index.pattern	225
abstract_inverted_index.present	71
abstract_inverted_index.studied	30
abstract_inverted_index.subsets	23, 242
abstract_inverted_index.≤33%,	85
abstract_inverted_index.Abstract	0
abstract_inverted_index.Canadian	34
abstract_inverted_index.However,	235
abstract_inverted_index.Myopathy	36
abstract_inverted_index.Nailfold	2
abstract_inverted_index.Videocap	51
abstract_inverted_index.abnormal	93, 178
abstract_inverted_index.acquired	46
abstract_inverted_index.although	222
abstract_inverted_index.compared	114
abstract_inverted_index.describe	18
abstract_inverted_index.duration	149
abstract_inverted_index.features	110
abstract_inverted_index.frequent	157, 219
abstract_inverted_index.included	120
abstract_inverted_index.myositis	138, 209, 249
abstract_inverted_index.patterns	99, 112, 189
abstract_inverted_index.ramified	64
abstract_inverted_index.subjects	31, 176
abstract_inverted_index.subsets.	117
abstract_inverted_index.syndrome	171, 217
abstract_inverted_index.33–66%,	88
abstract_inverted_index.Capillary	54
abstract_inverted_index.Ectasias,	61
abstract_inverted_index.approach.	27
abstract_inverted_index.capillary	162
abstract_inverted_index.decreased	161
abstract_inverted_index.described	8
abstract_inverted_index.inclusion	136, 207, 247
abstract_inverted_index.myopathy,	134, 206, 246
abstract_inverted_index.subjects:	123
abstract_inverted_index.syndrome,	130
abstract_inverted_index.syndrome.	198
abstract_inverted_index.Conclusion	212
abstract_inverted_index.Objectives	1
abstract_inverted_index.associated	227
abstract_inverted_index.autoimmune	10
abstract_inverted_index.described.	108
abstract_inverted_index.myopathies	12
abstract_inverted_index.particular	230
abstract_inverted_index.0.4–2.8].	154
abstract_inverted_index.abnormality	159
abstract_inverted_index.alterations	5
abstract_inverted_index.capillaries	65, 95
abstract_inverted_index.distinguish	239
abstract_inverted_index.necrotizing	133, 205, 245
abstract_inverted_index.prospective	40
abstract_inverted_index.scleroderma	101
abstract_inverted_index.Inflammatory	35
abstract_inverted_index.capillaries,	63
abstract_inverted_index.discriminant	192
abstract_inverted_index.inflammatory	11
abstract_inverted_index.non-specific	181
abstract_inverted_index.standardized	77
abstract_inverted_index.abnormalities	20, 200
abstract_inverted_index.non-specific,	104
abstract_inverted_index.polymyositis.	141, 211, 251
abstract_inverted_index.Qualitatively,	173
abstract_inverted_index.abnormalities,	183, 221
abstract_inverted_index.quantitatively	58
abstract_inverted_index.scleromyositis	167, 195, 214
abstract_inverted_index.anti-synthetase	129, 170, 197, 216
abstract_inverted_index.dermatomyositis	165
abstract_inverted_index.immune-mediated	132, 204, 244
abstract_inverted_index.magnification).	53
abstract_inverted_index.scleromyositis,	127
abstract_inverted_index.Dermatomyositis,	213
abstract_inverted_index.dermatomyositis,	125, 194
abstract_inverted_index.microhemorrhages	67
abstract_inverted_index.capillaries/total	94
abstract_inverted_index.scleroderma-like,	103
abstract_inverted_index.semi-quantitative	78
abstract_inverted_index.early/active/late,	102
abstract_inverted_index.videocapillaroscopy	3
abstract_inverted_index.semi-quantitatively.	60
abstract_inverted_index.clinico-sero-pathological	26
cited_by_percentile_year
countries_distinct_count	1
institutions_distinct_count	8
citation_normalized_percentile.value	0.7928394
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False